FAS and neoplasm: Consistent with the increased Fas protein level, 5-FU therapy suppressed splenomegaly (Figure 3C) and significantly decreased MDSC accumulation in the tumor (Figure 3B), spleen (Figure 3E), and bone marrow (Figure 3G) in the tumor-bearing mice.